Peptide Research Protocols

5-Amino-1MQ

A small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor studied for its effects on cellular energy metabolism, adipocyte differentiation, and lipid accumulation in obesity models.

Typical Dose Range 50 - 150 mg

Frequency 1 - 2x daily (oral)

Cycle Length 4 - 12 weeks

Reconstitution Oral capsule / no recon

Administration: Oral or subcutaneous, depending on formulation
Mechanism: Inhibits NNMT enzyme, increasing intracellular NAD+ and SAM levels in adipose tissue
Storage: Store lyophilized powder at -20°C; reconstituted at 2-8°C
Note: Published in Biochemical Pharmacology (2020) showing dose-dependent reduction in fat cell size and lipid content in murine models

AOD 9604

A modified hGH fragment (177-191) researched for lipolytic activity without affecting IGF-1 levels or insulin resistance. Originally developed for metabolic research.

Typical Dose Range 300 - 600 mcg

Frequency 1x daily

Cycle Length 8 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection in abdominal fat area
Timing: Morning on an empty stomach, 30 min before food
Storage: Reconstituted at 2-8°C, use within 30 days
Note: Does not affect blood sugar or tissue growth — considered safe for metabolic research

BPC-157

Body Protection Compound-157. A pentadecapeptide studied for cytoprotective properties and tissue repair signaling in gastrointestinal, tendon, and ligament models.

Typical Dose Range 200 - 500 mcg

Frequency 1 - 2x daily

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection, ideally near the area of interest
Loading Phase: Some protocols use 500 mcg 2x/day for the first 1-2 weeks
Maintenance: 250 mcg 1-2x/day for remaining cycle
Storage: Reconstituted solution at 2-8°C, use within 30 days
Stacking: Commonly researched alongside TB-500 for synergistic tissue repair

CJC-1295 With DAC

A modified GHRH analog conjugated with a Drug Affinity Complex (DAC) for extended half-life. Studied for sustained GH elevation over days rather than hours.

Typical Dose Range 1 - 2 mg

Frequency 1 - 2x per week

Cycle Length 8 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Half-Life: ~6-8 days due to DAC conjugation with albumin binding
Timing: Typically administered once or twice weekly; timing is less critical due to extended half-life
Storage: Reconstituted at 2-8°C, use within 30 days
Note: Produces a sustained GH "bleed" rather than pulsatile release. Not typically stacked with GHRP due to continuous elevation

CJC-1295 Without DAC (Mod GRF 1-29)

A modified growth hormone-releasing factor (1-29) analog without the Drug Affinity Complex. Stimulates pulsatile GH release mimicking natural physiology.

Typical Dose Range 100 - 300 mcg

Frequency 2 - 3x daily

Cycle Length 8 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection on an empty stomach
Half-Life: ~30 minutes — requires multiple daily administrations
Stacking: Most commonly combined with Ipamorelin for synergistic GHRH + GHRP pulsatile GH release
Timing: Morning, post-workout, and/or before bed (20 min before food)
Storage: Reconstituted at 2-8°C, use within 30 days

Epitalon

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied for telomerase activation, pineal gland function, and cellular senescence pathways.

Typical Dose Range 5 - 10 mg

Frequency 1x daily for 10-20 days

Cycle Length 10-20 days, 2-3x/year

Reconstitution 2 mL BAC water

Administration: Subcutaneous or intramuscular injection
Protocol: 10 mg daily for 10 consecutive days, repeated 2-3 times per year
Storage: Reconstituted at 2-8°C, use within 30 days
Note: Based on Khavinson's bioregulator research at the St. Petersburg Institute

GHK-Cu

A copper-binding tripeptide found in human plasma. Researched for collagen synthesis, wound healing, anti-inflammatory signaling, and gene expression modulation.

Typical Dose Range 1 - 3 mg

Frequency 1x daily

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection or topical application
Timing: Morning or evening — consistent timing recommended
Stacking: Often combined with BPC-157 and TB-500 in "Glow Blend" formulations
Storage: Reconstituted at 2-8°C, use within 30 days. Solution may appear slightly blue due to copper content

Glow Blend (GHK-Cu / BPC-157 / TB-500)

A three-peptide blend studied for potential synergistic effects on tissue repair, collagen remodeling, and regenerative signaling pathways.

Typical Dose Range 0.3 - 0.5 mL

Frequency 1x daily or 5x/week

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Components: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg per vial
Storage: Reconstituted at 2-8°C, solution may be slightly blue from copper
Note: Triple-peptide approach targets collagen, tissue repair, and anti-inflammatory pathways simultaneously

GLP-2 TZ

A glucagon-like peptide-2 analog studied for intestinal mucosal growth, nutrient absorption enhancement, and gut barrier integrity in short bowel and GI research models.

Typical Dose Range 0.05 - 0.1 mg/kg

Frequency 1x daily

Cycle Length 4 - 24 weeks

Reconstitution 1 mL BAC water

Administration: Subcutaneous injection in the abdomen
Mechanism: Binds GLP-2 receptors on intestinal subepithelial myofibroblasts, promoting crypt cell proliferation and villus growth
Storage: Reconstituted at 2-8°C, use within 30 days
Note: Teduglutide (GLP-2 analog) is FDA-approved for short bowel syndrome under the brand name Gattex

GLP-3 RT

A triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Researched for multi-pathway metabolic modulation, energy expenditure, and hepatic lipid metabolism.

Typical Dose Range 0.5 - 12 mg (titrated)

Frequency 1x weekly

Cycle Length 12 - 48 weeks

Reconstitution Varies by concentration

Administration: Subcutaneous injection in abdomen, thigh, or upper arm
Titration: Start at lowest dose (0.5 mg) and escalate every 4 weeks to minimize GI side effects
Storage: Reconstituted at 2-8°C
Note: Phase 2 trials (Eli Lilly) reported up to 24% body weight reduction at 48 weeks. First triple-agonist in clinical development

Glutathione

A tripeptide (L-glutamate, L-cysteine, glycine) serving as the body's master antioxidant. Researched for oxidative stress reduction, detoxification support, and mitochondrial protection.

Typical Dose Range 200 - 600 mg

Frequency 1 - 3x per week

Cycle Length Ongoing / 4-12 weeks

Reconstitution Pre-reconstituted

Administration: Subcutaneous, intramuscular, or IV push (clinical settings)
Mechanism: Neutralizes reactive oxygen species (ROS), regenerates vitamins C and E, supports Phase II liver detoxification
Stacking: Often combined with NAD+ for synergistic cellular protection protocols
Storage: Store at 2-8°C, protect from light. Oxidizes rapidly once opened
Note: IV glutathione has been studied in Parkinson's disease, NAFLD, and chemotherapy-induced toxicity models

Ipamorelin

A selective GH secretagogue acting on the ghrelin receptor (GHS-R). Stimulates GH release without significantly affecting cortisol or prolactin.

Typical Dose Range 200 - 300 mcg

Frequency 2 - 3x daily

Cycle Length 8 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection, preferably on an empty stomach
Timing: Morning, post-workout, and/or before bed (20 min before food)
Stacking: Commonly combined with CJC-1295 (no DAC) for synergistic GH release
Storage: Reconstituted at 2-8°C, use within 30 days
Note: One of the cleanest GH secretagogues with minimal side effects in studies

KissPeptin

A neuropeptide encoded by the KISS1 gene that acts upstream of GnRH neurons. Researched for its role in regulating the hypothalamic-pituitary-gonadal axis, pubertal onset, and fertility signaling.

Typical Dose Range 0.1 - 1.0 nmol/kg

Frequency 1x daily or as needed

Cycle Length 2 - 4 weeks

Reconstitution 1 mL BAC water

Administration: Subcutaneous or IV injection
Mechanism: Activates KISS1R on GnRH neurons, triggering pulsatile GnRH release and subsequent LH/FSH secretion
Timing: Single bolus dosing in most clinical research protocols
Storage: Reconstituted at 2-8°C, use within 14 days
Note: Published in NEJM and J Clin Endocrinol Metab for reproductive function research in hypothalamic amenorrhea

KLOW Blend (GHK-Cu / KPV / BPC-157 / TB-500)

A four-peptide blend combining tissue repair, anti-inflammatory, and collagen remodeling peptides. Expands on the Glow Blend formula with the addition of KPV.

Typical Dose Range 0.3 - 0.5 mL

Frequency 1x daily or 5x/week

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Components: GHK-Cu 50mg + KPV 10mg + BPC-157 10mg + TB-500 10mg per vial
Advantages: Adds KPV's alpha-MSH-derived anti-inflammatory action to the Glow Blend formula
Storage: Reconstituted at 2-8°C, solution may be slightly blue from copper. Use within 30 days
Note: Four-pathway approach targets collagen synthesis, tissue repair, anti-inflammatory modulation, and cell migration

KPV

A C-terminal tripeptide fragment of alpha-MSH (Lys-Pro-Val) with potent anti-inflammatory properties. Researched for NF-kB pathway inhibition, gut mucosal healing, and immune modulation.

Typical Dose Range 200 - 500 mcg

Frequency 1 - 2x daily

Cycle Length 4 - 8 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection or oral (encapsulated for gut-targeted research)
Mechanism: Inhibits NF-kB nuclear translocation and reduces pro-inflammatory cytokine expression (IL-1b, TNF-a, IL-6)
Stacking: Combined with BPC-157 for gut-focused research or with GHK-Cu in KLOW Blend
Storage: Reconstituted at 2-8°C, use within 30 days
Note: Published in PLoS ONE and Inflammatory Bowel Diseases for colitis model research. Retains anti-inflammatory activity without melanocortin receptor binding

LL-37

The only human cathelicidin-derived antimicrobial peptide. Researched for broad-spectrum antimicrobial activity, biofilm disruption, wound healing modulation, and innate immune signaling.

Typical Dose Range 50 - 100 mcg

Frequency 1x daily

Cycle Length 2 - 6 weeks

Reconstitution 1 mL BAC water

Administration: Subcutaneous injection near area of interest, or topical in wound research
Mechanism: Disrupts microbial membranes via electrostatic interactions; modulates TLR signaling and chemokine expression
Starting Dose: Begin at lower range (50 mcg) to assess response
Storage: Reconstituted at 2-8°C, use within 14 days. Sensitive to freeze-thaw cycles
Note: Extensively published in J Immunol and Antimicrobial Agents and Chemotherapy for activity against MRSA, Pseudomonas, and Candida biofilms

MOTS-c

A mitochondrial-derived peptide encoded within the 12S rRNA gene. Researched for AMPK pathway activation, glucose regulation, exercise mimetic effects, and metabolic homeostasis.

Typical Dose Range 5 - 10 mg

Frequency 3 - 5x per week

Cycle Length 4 - 8 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Mechanism: Activates AMPK, promotes glucose uptake independent of insulin, and translocates to the nucleus during metabolic stress
Timing: Morning dosing often preferred; can be administered pre-exercise in research protocols
Storage: Reconstituted at 2-8°C, use within 30 days
Note: Published in Cell Metabolism (2015) by Lee et al. Shown to improve insulin sensitivity and prevent diet-induced obesity in murine models

NAD+

Nicotinamide adenine dinucleotide at high concentration. Studied for cellular energy metabolism, sirtuin activation, and DNA repair mechanisms.

Typical Dose Range 50 - 200 mg

Frequency 1x daily or 2-3x/week

Cycle Length Ongoing / 4-12 weeks

Reconstitution Pre-reconstituted (5mL)

Administration: Subcutaneous or intramuscular injection. IV administration studied in clinical settings
Starting Dose: Begin at 50-100 mg to assess tolerance
Storage: Store at 2-8°C, protect from light
Note: May cause flushing or warmth at injection site — this is normal and temporary

Selank

A synthetic analog of tuftsin with anxiolytic-like activity. Researched for effects on BDNF expression, serotonergic systems, and immune modulation.

Typical Dose Range 250 - 500 mcg

Frequency 1 - 2x daily

Cycle Length 2 - 4 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection or intranasal spray
Timing: Morning and/or early afternoon — avoid late evening
Storage: Reconstituted at 2-8°C, use within 30 days
Note: Approved as a prescription drug in Russia. Non-addictive in studies with no withdrawal reported

Semax

A synthetic analog of ACTH(4-10) with nootropic and neuroprotective properties. Researched for BDNF upregulation, cognitive enhancement, and cerebrovascular support.

Typical Dose Range 200 - 600 mcg

Frequency 1 - 3x daily

Cycle Length 2 - 4 weeks

Reconstitution 2 mL BAC water

Administration: Intranasal spray or subcutaneous injection
Mechanism: Modulates BDNF and NGF expression, enhances dopaminergic and serotonergic neurotransmission
Timing: Morning and early afternoon dosing — avoid evening to prevent sleep disruption
Storage: Reconstituted at 2-8°C, use within 30 days
Note: Approved in Russia for treatment of stroke and cognitive impairment. Published in Neuroscience Letters for neuroprotective and neurotrophic effects

SLU-PP-332

An ERR (estrogen-related receptor) agonist studied as an exercise mimetic. Researched for effects on mitochondrial biogenesis, fatty acid oxidation, and exercise capacity without physical activity.

Typical Dose Range 10 - 50 mg/kg (animal)

Frequency 1x daily

Cycle Length 4 - 8 weeks

Reconstitution 1 mL BAC water

Administration: Subcutaneous injection
Mechanism: Activates ERRa, ERRb, and ERRy transcription factors, inducing mitochondrial biogenesis and oxidative muscle fiber gene expression
Timing: Morning dosing in preclinical models
Storage: Reconstituted at 2-8°C, protect from light, use within 14 days
Note: Published in J Med Chem (2023) by Bhatt et al. at Washington University. Shown to increase running endurance in sedentary mice by ~50% and reduce muscle fatigue resistance

SS-31 (Elamipretide)

A mitochondria-targeted tetrapeptide that selectively binds cardiolipin on the inner mitochondrial membrane. Researched for restoring electron transport chain efficiency and reducing oxidative stress.

Typical Dose Range 0.5 - 5 mg

Frequency 1x daily

Cycle Length 4 - 12 weeks

Reconstitution 1 mL BAC water

Administration: Subcutaneous injection. IV infusion used in clinical trials
Mechanism: Binds cardiolipin to stabilize cytochrome c interaction, optimizes electron transport, and reduces mitochondrial ROS production
Storage: Reconstituted at 2-8°C, use within 14 days. Protect from light
Note: Advanced through multiple Phase 2/3 clinical trials (Stealth BioTherapeutics) for Barth syndrome, heart failure, and mitochondrial myopathy. Published in JACC and Br J Pharmacol

Tesamorelin

A synthetic GHRH analog studied for its effects on GH secretion and reduction of visceral adipose tissue. One of the few peptides with FDA-approved indications.

Typical Dose Range 1 - 2 mg

Frequency 1x daily

Cycle Length 8 - 26 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection in the abdomen
Timing: Morning on an empty stomach or before bed
Storage: Reconstituted at 2-8°C, use within 30 days
Note: FDA-approved for HIV-associated lipodystrophy under the brand name Egrifta

Thymalin

A thymic peptide bioregulator researched for immunomodulatory effects, T-cell maturation, thymus function restoration, and neuroendocrine-immune interactions.

Typical Dose Range 5 - 10 mg

Frequency 1x daily for 10 days

Cycle Length 10 days, 1-2x/year

Reconstitution 2 mL BAC water

Administration: Intramuscular or subcutaneous injection
Protocol: 10 mg daily for 10 consecutive days, 1-2 courses per year
Stacking: Often combined with Epitalon in bioregulator protocols
Storage: Reconstituted at 2-8°C, use within 14 days

TB-500 (Thymosin Beta-4)

A 43-amino-acid peptide involved in actin regulation and cell migration. Studied for wound healing, angiogenesis, and anti-inflammatory activity.

Typical Dose Range 2 - 5 mg

Frequency 2x per week

Cycle Length 4 - 8 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Loading Phase: 5 mg 2x/week for first 4 weeks
Maintenance: 2.5 mg 2x/week or 5 mg 1x/week
Storage: Reconstituted at 2-8°C, use within 30 days
Note: Systemic activity — injection site does not need to be near area of interest

Wolverine Blend (BPC-157 / TB-500)

A dual-peptide blend combining BPC-157 and TB-500 researched for synergistic tissue repair, angiogenesis, and anti-inflammatory effects.

Typical Dose Range 0.3 - 0.5 mL

Frequency 1x daily or 5x/week

Cycle Length 4 - 8 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection, ideally near area of interest
Advantages: Pre-mixed blend eliminates need to reconstitute and dose two separate vials
Storage: Reconstituted at 2-8°C, use within 30 days
Note: Most popular blend for tissue repair research

Thymosin Alpha-1

A 28-amino acid thymic peptide studied for T-cell maturation, dendritic cell activation, and broad immunomodulatory effects in immune research.

Typical Dose Range 1.5 mg SQ 2–3x/week

Frequency 2–3x/week

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

DSIP

Delta Sleep-Inducing Peptide, a neuropeptide studied for its role in sleep architecture modulation, stress response, and circadian rhythm regulation.

Typical Dose Range 100–200 mcg SQ nightly

Frequency Nightly

Cycle Length 2 - 4 weeks, cycle off

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Snap-8

Acetyl octapeptide-3, a topical neuropeptide studied for inhibiting SNARE complex formation to reduce muscle contraction-related wrinkle depth.

Typical Dose Range See protocol details

Frequency Twice daily

Cycle Length 4 - 8 weeks

Reconstitution Topical application

Administration: Topical application
Components: 10mg Topical
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Vitamin B12

Methylcobalamin/cyanocobalamin injection studied for neurological function support, red blood cell formation, and energy metabolism.

Typical Dose Range 0.5-1 mg 1-2x weekly IM or SQ

Frequency Weekly

Cycle Length 4 - 12 weeks

Reconstitution BAC water, SQ or IM

Administration: Subcutaneous or intramuscular injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

hCG

Human Chorionic Gonadotropin, a glycoprotein hormone studied for its LH-mimetic effects on Leydig cell stimulation, testosterone production, and fertility protocols.

Typical Dose Range 250-500 IU 2-3x weekly SQ

Frequency 2-3x weekly

Cycle Length Per protocol (4-8 weeks)

Reconstitution Per manufacturer directions

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

IGF-1 LR3

A long-acting analog of Insulin-like Growth Factor 1 with an extended half-life. Studied for muscle protein synthesis, cell proliferation, and anti-apoptotic signaling.

Typical Dose Range 0.2-0.5 mg post-workout or daily SQ

Frequency Once daily

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Melanotan II

A synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) studied for melanogenesis activation, tanning response, and MC4R-mediated appetite effects.

Typical Dose Range 0.25-0.5 mg 1-2x weekly SQ

Frequency 1-2x weekly

Cycle Length 4 - 8 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

PT-141

Bremelanotide — a melanocortin receptor agonist studied for sexual function through central MC3R/MC4R activation rather than peripheral vascular mechanisms.

Typical Dose Range 1-2 mg PRN (30-60 min pre-activity) SQ

Frequency PRN

Cycle Length 4 - 8 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

VIP-10

Vasoactive Intestinal Peptide, a neuropeptide studied for immunomodulation, anti-inflammatory signaling, and mucosal immune regulation research.

Typical Dose Range 0.5-1 mg daily SQ

Frequency Once daily

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

GLP-1 Agonist

Semaglutide — a GLP-1 receptor agonist studied for glucose-dependent insulin secretion, appetite suppression, and cardiovascular outcomes in metabolic research.

Typical Dose Range 0.25–2.4 mg SQ weekly

Frequency Weekly

Cycle Length 12+ weeks (dose titration)

Reconstitution Standard BAC water recon

Administration: Subcutaneous injection
Components: Semaglutide
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Sermorelin

A synthetic analog of GHRH (1-29) studied for physiologic pulsatile growth hormone release, improved sleep quality, and body composition in aging research.

Typical Dose Range 200–500 mcg SQ nightly

Frequency Nightly

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Cagrilintide

A long-acting amylin analog studied for appetite regulation and weight management. Acts on amylin receptors to promote satiety signaling in metabolic research.

Typical Dose Range 0.25–4.5 mg SQ weekly

Frequency Weekly

Cycle Length 12+ weeks (dose titration)

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Cagrilintide / GLP-1 S Blend

A combination of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist) studied for synergistic metabolic effects in weight management research.

Typical Dose Range 0.25–2.4 mg SQ weekly

Frequency Weekly

Cycle Length 12+ weeks (dose titration)

Reconstitution Standard BAC water recon

Administration: Subcutaneous injection
Components: Cagrilintide 5mg / Semaglutide 5mg
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

ACE-031

A soluble form of activin receptor type IIB (ActRIIB-Fc) studied for its role in inhibiting myostatin signaling and promoting skeletal muscle growth in preclinical models.

Typical Dose Range 0.1–0.3 mg SQ every 2 weeks

Frequency Every 2 weeks

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

AICAR

5-Aminoimidazole-4-carboxamide ribonucleotide, an AMPK activator studied for its effects on exercise mimicry, glucose uptake, and fatty acid oxidation in metabolic research.

Typical Dose Range 25–50 mg SQ daily

Frequency Once daily

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

FOXO4-DRI

A D-retro-inverso peptide designed to disrupt FOXO4–p53 interaction, studied for its senolytic properties — selectively clearing senescent cells in aging research.

Typical Dose Range 1–5 mg SQ every 3 days

Frequency Every 3 days

Cycle Length 10 - 20 days, repeat 2-3x/year

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

GDF-8

Growth Differentiation Factor 8 (Myostatin) inhibitor research peptide, studied for its effects on skeletal muscle hypertrophy and body composition.

Typical Dose Range 100–500 mcg SQ 2–3x/week

Frequency 2–3x/week

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

GHRP-6 Acetate

Growth Hormone Releasing Peptide-6, a potent hexapeptide ghrelin mimetic studied for robust GH release, appetite stimulation, and gastroprotective effects.

Typical Dose Range 100–300 mcg SQ 1–3x daily

Frequency 1–3x daily

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

HMG

Human Menopausal Gonadotropin containing FSH and LH activity, studied in fertility and hormonal research for gonadal stimulation.

Typical Dose Range 75 IU SQ/IM 2–3x weekly

Frequency 2–3x weekly

Cycle Length 4 - 8 weeks

Reconstitution BAC water, SQ or IM

Administration: Subcutaneous or intramuscular injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Hexarelin Acetate

A synthetic hexapeptide growth hormone secretagogue and ghrelin receptor agonist studied for potent GH release and cardioprotective properties.

Typical Dose Range 100–200 mcg SQ 1–2x daily

Frequency 1–2x daily

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Lipo Blend (8X)

An 8-component lipotropic injection blend combining L-Carnitine, L-Arginine, Methionine, Inositol, Choline, B6, B5, and B12 for metabolic support research.

Typical Dose Range 0.5–1 mL IM 1–2x weekly

Frequency 1–2x weekly

Cycle Length 4 - 12 weeks

Reconstitution IM injection, no recon needed if pre-mixed

Administration: Intramuscular injection
Components: L-Carnitine / L-Arginine / Methionine / Inositol / Choline / B6 / B5 / B12
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

MIC Blend (4X)

A lipotropic combination of Methionine, Inositol, Choline, and Carnitine with Dexpanthenol, studied for hepatic fat metabolism and lipid transport support.

Typical Dose Range 0.5–1 mL IM 1–2x weekly

Frequency 1–2x weekly

Cycle Length 4 - 12 weeks

Reconstitution IM injection, no recon needed if pre-mixed

Administration: Intramuscular injection
Components: Methionine 15mg / Choline Chloride 50mg / Carnitine 50mg / Dexpanthenol 5mg
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Mazdutide

A dual GLP-1/glucagon receptor agonist studied for simultaneous incretin and glucagon pathway activation in obesity and metabolic syndrome research.

Typical Dose Range 1–9 mg SQ weekly

Frequency Weekly

Cycle Length 12+ weeks (dose titration)

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Pinealon

A tripeptide bioregulator (Glu-Asp-Arg) studied for pineal gland function, melatonin regulation, and neuroprotective effects on sleep-wake cycle.

Typical Dose Range 5–10 mg SQ daily

Frequency Once daily

Cycle Length 2 - 4 weeks, cycle off

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

PNC-27

A peptide containing an HDM-2 binding domain linked to a membrane-penetrating sequence, studied for selective cytotoxicity in cancer cell research models.

Typical Dose Range 1–2 mg SQ daily

Frequency Once daily

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

ARA-290

A non-erythropoietic peptide derived from erythropoietin, studied for neuroprotective and tissue-protective properties via the innate repair receptor (IRR).

Typical Dose Range 2–4 mg SQ daily

Frequency Once daily

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Survodutide

A dual GLP-1/glucagon receptor agonist studied for combined incretin and glucagon signaling in metabolic and hepatic fat reduction research.

Typical Dose Range 0.3–4.8 mg SQ weekly

Frequency Weekly

Cycle Length 12+ weeks (dose titration)

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

IGF-DES

Des(1-3) IGF-1 — a truncated IGF-1 variant with 10x higher potency due to reduced IGF binding protein affinity. Studied for localized tissue growth.

Typical Dose Range 50–100 mcg SQ post-workout

Frequency Post-workout or daily

Cycle Length 4 - 12 weeks

Reconstitution 2 mL BAC water

Administration: Subcutaneous injection
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

GH Blend (4X)

A multi-component growth hormone secretagogue blend combining GHRP-2, Tesamorelin, MGF, and Ipamorelin for comprehensive GH axis stimulation research.

Typical Dose Range 0.1–0.3 mL SQ nightly

Frequency Nightly

Cycle Length 4 - 12 weeks

Reconstitution Standard BAC water recon

Administration: Subcutaneous injection
Components: GHRP-2 5mg / Tesamorelin 5mg / MGF 500mcg / Ipamorelin 2.5mg
Storage: Store lyophilized at -20°C; reconstituted at 2-8°C, use within 30 days
Source: Protocol data referenced from PeptideDosing.Guide

Peptide Research Protocols

5-Amino-1MQ

AOD 9604

BPC-157

CJC-1295 With DAC

CJC-1295 Without DAC (Mod GRF 1-29)

Epitalon

GHK-Cu

Glow Blend (GHK-Cu / BPC-157 / TB-500)

GLP-2 TZ

GLP-3 RT

Glutathione

Ipamorelin

KissPeptin

KLOW Blend (GHK-Cu / KPV / BPC-157 / TB-500)

KPV

LL-37

MOTS-c

NAD+

Selank

Semax

SLU-PP-332

SS-31 (Elamipretide)

Tesamorelin

Thymalin

TB-500 (Thymosin Beta-4)

Wolverine Blend (BPC-157 / TB-500)

Thymosin Alpha-1

DSIP

Snap-8

Vitamin B12

hCG

IGF-1 LR3

Melanotan II

PT-141

VIP-10

GLP-1 Agonist

Sermorelin

Cagrilintide

Cagrilintide / GLP-1 S Blend

ACE-031

AICAR

FOXO4-DRI

GDF-8

GHRP-6 Acetate

HMG

Hexarelin Acetate

Lipo Blend (8X)

MIC Blend (4X)

Mazdutide

Pinealon

PNC-27

ARA-290

Survodutide

IGF-DES

GH Blend (4X)

Calculate Your Doses